Like IL-6, VEGF stimulates the migration and invasion of NSCLC cells [14], and VEGF expression in NSCLC is associated with more advanced TNM stage, dedifferentiation, lymph-node involvement and poorer prognosis [15]. Here, IL6 is linked to non-small cell lung carcinoma.